文献速递湿疹皮炎与荨麻疹

全球特应性皮炎疾病负担:1990-2017年全球疾病负担研究

The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2017.
PubMed 文献 · Br J Dermatol · 2020-11-29

该研究基于全球疾病负担(GBD)研究,提取1990至2017年特应性皮炎(AD)的负担数据。AD在非致死性疾病中排名第15位,在皮肤病中伤残调整生命年(DALYs)负担最高。

要点

  • AD是全球皮肤病中DALYs负担最高的疾病,在非致死性疾病中排第15位。
  • 1990至2017年全球AD的DALY率保持稳定,但地理分布差异显著。
  • AD年龄分布呈双峰曲线,早童年最高,中老年出现第二峰,且疾病负担与GDP呈中度正相关。

核心结论

  • GBD数据证实AD全球负担巨大,自1990年以来保持稳定但地理变异显著。
  • 生活方式因素(部分与富裕相关)可能是重要的疾病驱动因素。

研究设计与样本

  • 基于GBD研究的疾病负担分析,数据覆盖1990年至2017年。

主要发现

  • AD在非致死性疾病中排名第15位,在皮肤病中DALYs负担最高。
  • DALY率最高的国家为瑞典(327,95%UI 178-547)、英国(284,95%UI 155-478)和冰岛(277,95%UI 149-465)。

关键数值与推荐

  • AD年龄分布呈双峰曲线,早童年峰值最高,年轻成人患病率下降,中老年出现第二峰。
  • 国家GDP与AD疾病负担呈中度正相关。

临床怎么用

  • 临床应认识到AD在全球范围内负担沉重且地理差异大,需结合当地流行病学特点进行管理。
  • 关注AD的双峰年龄分布,对中老年患者也应保持警惕。

局限性

  • GBD方法学需进一步发展以纳入环境风险因素(如紫外线暴露),以更好理解地理和年龄相关变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Global Burden of Disease (GBD) Study provides an annually updated resource to study disease-related morbidity and mortality worldwide. OBJECTIVES: Here we present the burden estimates for atopic dermatitis (AD), including data from inception of the GBD project in 1990 until 2017. METHODS: Data on the burden of AD were obtained from the GBD Study. RESULTS: Atopic dermatitis (AD) ranks 15th among all nonfatal diseases and has the highest disease burden among skin diseases as measured by disability-adjusted life-years (DALYs). Overall, the global DALY rate for AD in 1990 was 121 [95% uncertainty interval (UI) 65·4-201] and remained similar in 2017 at 123 (95% UI 66·8-205). The three countries with the highest DALY rates of AD were Sweden (327, 95% UI 178-547), the UK (284, 95% UI 155-478) and Iceland (277, 95% UI 149-465), whereas Uzbekistan (85·1, 95% UI 45·2-144), Armenia (85·1, 95% UI 45·8-143) and Tajikistan (85·1, 95% UI 46·1-143) ranked lowest. CONCLUSIONS: The global prevalence rate of AD has remained stable from 1990 to 2017. However, the distribution of AD by age groups shows a bimodal curve with the highest peak in early childhood, decreasing in prevalence among young adults, and a second peak in middle-aged and older populations. We also found a moderate positive correlation between a country's gross domestic product and disease burden. GBD data confirm the substantial worldwide burden of AD, which has remained stable since 1990 but shows significant geographical variation. Lifestyle factors, partially linked to affluence, are likely important disease drivers. However, the GBD methodology needs to be developed further to incorporate environmental risk factors, such as ultraviolet exposure, to understand better the geographical and age-related variations in disease burden.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Laughter MR, Maymone MBC, Mashayekhi S, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2017. Br J Dermatol. 2020. PMID: 33006135. doi:10.1111/bjd.19580

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。